Shanghai Pharmaceuticals Holding Co., Ltd
601607
株式のランク
#2387
Shanghai Pharmaceuticals Holding Co., Ltd., a diversified investment holding... Shanghai Pharmaceuticals Holding Co., Ltd., a diversified investment holding entity established in 1994 and headquartered in Shanghai, China, plays a crucial role in the People's Republic of China's pharmaceutical and healthcare sectors. As a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd., its extensive operations encompass research, development, manufacturing, distribution, and retail of a wide array of products. The company's business model is structured around four principal segments: Production, Distribution, Retail, and an 'Others' category. Within its Production segment, it develops and manufactures a broad portfolio of pharmaceuticals, including chemical and biochemical drugs, traditional Chinese medicines, healthcare solutions, and medical devices. These offerings target diverse therapeutic fields such as oncology, cardiovascular and cerebrovascular conditions, central nervous system disorders, general infections, immunological diseases, digestive and metabolic ailments, and respiratory issues. The company's product range comprises approximately 700 distinct drug varieties. Beyond manufacturing, its Distribution arm is instrumental in providing comprehensive pharmaceutical supply chain solutions. This includes warehousing, logistics, and value-added services for various industry players, from pharmaceutical manufacturers to dispensers like hospitals, other distributors, and retail pharmacies. Furthermore, the company manages an extensive network of retail pharmacies, alongside a burgeoning online drug sales platform. This retail footprint spans approximately 2,000 chain pharmacies across 24 provinces. Its 'Others' segment encompasses a variety of support and innovative services, such as consulting, asset management, clinical trial coordination, medical assistance programs, educational initiatives for healthcare professionals and patients, e-prescription management systems, and the development of remote and cloud hospital technologies.
株価
$2.43
時価総額
$8.09B
変化（1日）
-1.16%
変化（1年）
-5.94%
国
CN
取引 Shanghai Pharmaceuticals Holding Co., Ltd (601607)
カテゴリー
Healthcare
Shanghai Pharmaceuticals Holding Co., Ltd（601607）のP/E比率
2026 時点のP/E比率 TTM 0
Shanghai Pharmaceuticals Holding Co., Ltd の最新の財務報告および株価によると、現在の P/E (TTM) は 0 です。2026 年末時点での P/E は 0 でした。
Shanghai Pharmaceuticals Holding Co., Ltd の P/E 比率の履歴（2001 〜 2026）
各年末のP/E比率
| 年 | P/E比率 | 変化 |
|---|---|---|
| 2025 | 11.60 | -32.13% |
| 2024 | 17.09 | 4.19% |
| 2023 | 16.40 | 48.37% |
| 2022 | 11.05 | -0.29% |
| 2021 | 11.09 | -8.65% |
| 2020 | 12.14 | -5.13% |
| 2019 | 12.79 | 7.07% |
| 2018 | 11.95 | -35.65% |
| 2017 | 18.57 | 12.84% |
| 2016 | 16.45 | -11.57% |
| 2015 | 18.61 | 8.74% |
| 2014 | 17.11 | -4.75% |
| 2013 | 17.97 | 23.58% |
| 2012 | 14.54 | 10.80% |
| 2011 | 13.12 | -58.75% |
| 2010 | 31.81 | -80.24% |
| 2009 | 160.94 | 221.88% |
| 2008 | 50.00 | -59.78% |
| 2007 | 124.31 | 208.48% |
| 2006 | 40.30 | 28.12% |
| 2005 | 31.45 | 47.65% |
| 2004 | 21.30 | 15.77% |
| 2003 | 18.40 | -31.84% |
| 2002 | 27.00 | 12.69% |
| 2001 | 23.96 | 0.00% |
類似企業や競合他社のP/E比率
| 企業 | P/E比率 | P/E比率の差 | 国 |
|---|---|---|---|
| 26.02 | - |
US
|
|
| - | - |
US
|
|
| 34.08 | - |
US
|
|
| - | - |
US
|
|
| 45.62 | - |
AU
|
P/E比率の読み方
株価収益率（P/E Ratio）は、企業の株価と1株あたり利益の関係を示します。
低いが正のP/Eは、現在の評価額に対して高い利益を上げている企業を示し、割安と見なされる可能性があります。高い負の（0に近い）P/Eは、損失が大きいことを示します。
P/Eが30を超えるか、負である企業は一般に「成長株」と見なされ、投資家は将来的な成長または黒字化を期待しています。
10未満の正のP/Eを持つ企業は一般に「割安株」と見なされ、既に収益性が高いが成長の余地は小さいと見なされます。